Efficacy and Safety Study of SyB L-0501 for Patients With Multiple Myeloma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study objectives of this study are to determine the effects, safety, and pharmacokinetics
of bendamustine for multiple myeloma to a regimen of bendamustine and prednisolone.